Precise But (Not Yet) Personal

“President Obama’s new initiative to fund genetic sequencing could be a powerful tool for good in improving U.S. health care—but only if the medical establishment welcomes it.” That’s the view of Duke Chancellor Emeritus, Ralph Snyderman, MD in a recent article in The American Interest. In the article, he explains, “On January 30, 2015, President […]

Ten Years into Personalized Medicine: What We’ve Learned and What’s Next

Ralph Snyderman, M.D. ORIGINAL SOURCE Ten years ago, the sequencing of the entire human genome, along with the development of aggregate “omics” technologies began giving rise to a fundamentally new capability for the practice of medicine – the ability to predict and track disease risks on a personalized basis, to understand diseases mechanistically, and to […]